Table 3.
Adjusted* Means for Patient Reported Outcomes by Obesity Status
Obese by FMI ≥ 13 kg/m2 | Obese by BMI ≥ 30 kg/m2 | |||||
---|---|---|---|---|---|---|
|
|
|||||
Yes | No | P | Yes | No | P | |
Disease Activity (SLAQ) | 14.8 (12.7–16.9) | 11.5 (10.1–12.9) | 0.01 | 14.7 (12.6–16.9) | 11.6 (10.2–13.1) | 0.02 |
Depression (CES-D) | 19.8 (16.1–23.4) | 13.1 (10.6–15.6) | 0.004 | 20.3 (16.5–24.0) | 13.1 (10.7–15.5) | 0.003 |
Pain (SF-36 Pain) † | 38.7 (35.7–41.7) | 44.2 (42.2–46.3) | 0.004 | 38.2 (35.1–41.3) | 44.2 (42.1–46.1) | 0.003 |
Fatigue (SF-36 Vitality) † | 39.6 (36.2–43.0) | 45.2 (42.9–47.6) | 0.01 | 38.0 (34.5–41.4) | 45.7 (43.4–47.9) | <0.001 |
Adjusted means calculated based on multivariate linear regression adjusted for age, race, education, income, smoking, disease duration, disease damage (Brief Index of Lupus Damage score), and prednisone use. P-values by Wilcoxon rank-sum test.
Higher scores reflect better status (less pain/fatigue)
SLAQ – Systemic Lupus Activity Questionnaire
CES-D – Center for Epidemiologic Studies Depression Scale
SF-36 – Short Form 36 Health Survey